Results 291 to 300 of about 249,531 (314)

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs

Expert Opinion on Drug Safety, 2013
Vishvas Garg, Dennis W Raisch, Steven M Trifilio   +2 more
exaly  

The United States Food and Drug Administration

2019
openaire   +1 more source

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

Pharmacotherapy, 2008
Felix W Frueh, Shashi Amur, Robert S Epstein   +2 more
exaly  

Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration

Pharmacotherapy, 2011
Issam Zineh
exaly  

United States Food and Drug Administration Regulation of Human Cells, Tissues, and Gene Therapies

Advances in Experimental Medicine and Biology, 2023
exaly  

Drug‐Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database

Pharmacotherapy, 2018
Hanna K Welch
exaly  

Small-Incision Lenticule Extraction (SMILE) for the Correction of Myopia with Astigmatism

Ophthalmology, 2020
Stephen Slade, Stefanie Seifert, Steven C Schallhorn   +2 more
exaly  

The burden of rare cancers in the United States

Ca-A Cancer Journal for Clinicians, 2017
Carol Desantis, Ahmedin Jemal
exaly  

United States Department of Agriculture. Food and Drug Administration

The Analyst, 1930
openaire   +1 more source

Adverse drug event reports at the United States Food and Drug Administration Center for Veterinary Medicine

Journal of the American Veterinary Medical Association, 2004
Victoria A, Hampshire, Frederick M, Doddy, Lynn O, Post, Teresa L, Koogler, Tina M, Burgess, Priscilla O, Batten, Roderick, Hudson, Dorothy R, McAdams, Margarita A, Brown   +8 more
openaire   +2 more sources